NVS logo

Novartis AG (NVS)

Profile

Full Name

Novartis AG

Ticker Symbol

NVS

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Switzerland

IPO

November 7, 1996

Indexes

Not included

Website

http://www.novartis.com

Employees

75883

Key Details

Price

$111.98

Market Cap

$221.17B(Mega cap)

Last Dividend

$3.87

TTM Dividend Yield

3.46%

Annual Revenue

$51.72B(+10.85% YoY)

Annual EPS

$5.87(-17.32% YoY)

PE Ratio

19.04

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$111.98
NVS price is $111.98

Price All-time High

$120.83
NVS price is currently -7.32% below its historical high of $120.83

Price Most Recent Change

+0.61%
NVS price was up +0.61% on Mar 28, 2025

Price YTD Change

+14.64%
NVS price is up +14.64% since January 1st

Price 1-year Change

+15.77%
NVS price is up +15.77% year-on-year

Price 3-year Change

+28.73%
NVS price is up +28.73% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$221.17B
NVS market capitalization is $221.17 billion

Market Cap 3-year Change

+13.76%
NVS market capitalization is up +13.76% over the past 3 years

Market Cap All-time High

$244.62B
NVS market capitalization is currently -9.59% below its historical high of $244.62 billion

Market Cap Sector Rank

99.34%
NVS market capitalization is higher than 99.34% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.37%
NVS shares outstanding is down -3.37% year-on-year

Shares Outstanding 3-Year Change

-11.63%
NVS shares outstanding is down -11.63% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.07
NVS beta is 0.07

200-day SMA

$108.70
NVS price is currently +3.02% above its 200-day simple moving average

50-day SMA

$107.75
NVS price is currently +3.92% above its 50-day simple moving average

RSI

57.69
NVS 14-day relative strength index is 57.69

Volume

1.01
NVS 30-day relative volume is 1.01

ATR

$1.73
NVS average true range is $1.73

10-day Historical Volatility

20.17%
NVS 10-day historical volatility is 20.17%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$3.87
NVS last dividend was $3.87 per share, with an ex-dividend date of March 12, 2025

Next Dividend

-
NVS next dividend has not yet been announced

Dividend per share

Dividend Per Share

$3.74
NVS annual dividend per share is $3.74

Dividend per share Sector Rank

89.41%
NVS annual dividend per share is higher than 89.41% of companies in Healthcare sector

Dividend per share 1-Year Change

+12.9%
NVS annual dividend per share is up +12.9% year-on-year

Dividend per share 3-Year Change

+23.48%
NVS annual dividend per share is up +23.48% over the past 3 years

Dividend yield

Dividend Yield

3.34%
NVS annual dividend yield is 3.34%

Dividend yield Sector Rank

72.62%
NVS annual dividend yield is higher than 72.62% of companies in Healthcare sector

Other

Payout Ratio

63.85%
NVS annual payout ratio is 63.85%

Dividends Paid

$7.62B
NVS annual dividends paid is $7.62 billion

Free Cash Flow

$13.80B
NVS annual free cash flow is $13.80 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$51.72B
NVS annual revenue is $51.72 billion

Revenue Analysts Estimate

$53.08B
NVS annual revenue is currently -2.55% lower than the consensus analysts' forecast

Revenue 1-year Change

+10.85%
NVS annual revenue is up +10.85% year-on-year

Revenue Sector Rank

98.19%
NVS annual revenue is higher than 98.19% of companies in Healthcare sector

EPS

EPS

$5.87
NVS annual earnings per share is $5.87

EPS Analysts Estimate

$8.43
NVS annual earnings per share is currently -30.37% lower than the consensus analysts' forecast

EPS 1-year Change

-17.32%
NVS annual earnings per share is down -17.32% year-on-year

EPS Sector Rank

96.43%
NVS annual earnings per share is higher than 96.43% of companies in Healthcare sector

Profit

Gross Profit

$38.90B
NVS annual gross profit is $38.90 billion

Gross Margin

75.20%
NVS annual gross profit margin is 75.20%

Operating Profit

$14.54B
NVS annual operating income is $14.54 billion

Operating Margin

28.12%
NVS annual operating profit margin is 28.12%

Net Income

$11.94B
NVS annual net profit is $11.94 billion

Net Margin

23.09%
NVS annual net profit margin is 23.09%

Expenses

Total Expenses

$37.18B
NVS annual total expenses is $37.18 billion

Operating Expenses

$24.35B
NVS annual total operating expenses is $24.35 billion

Cost Of Goods Sold

$12.83B
NVS annual cost of goods sold is $12.83 billion

Selling, General & Administrative Expenses

$12.57B
NVS annual SGA is $12.57 billion

Depreciation And Amortization

$6.07B
NVS annual depreciation & amortization is $6.07 billion

Interest Expense

$1.01B
NVS annual interest expense is $1.01 billion

Income Tax

$1.70B
NVS annual income tax is $1.70 billion

EBIT & EBITDA

EBIT

$14.65B
NVS annual earnings before interest & taxes is $14.65 billion

EBITDA

$20.71B
NVS annual EBITDA is $20.71 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$102.25B
NVS annual total assets is $102.25 billion

Non Current Assets

$72.54B
NVS annual long term assets is $72.54 billion

Current Assets

$29.70B
NVS annual total current assets is $29.70 billion

Cash And Cash Equivalents

$11.46B
NVS annual cash & cash equivalents is $11.46 billion

Accounts Receivable

$7.42B
NVS annual accounts receivable is $7.42 billion

Inventory

$5.72B
NVS annual inventory is $5.72 billion

Liabilities

Total Liabilities

$58.12B
NVS annual total liabilities is $58.12 billion

Long Term Liabilities

$29.43B
NVS annual total long term liabilities is $29.43 billion

Current Liabilities

$28.69B
NVS annual total current liabilities is $28.69 billion

Accounts Payable

$4.57B
NVS annual accounts payable is $4.57 billion

Debt

Total Debt

$31.26B
NVS annual total debt is $31.26 billion

Total Debt 1-year Change

+18.64%
NVS annual total debt is up +18.64% year-on-year

Long Term Debt

$22.93B
NVS annual long term debt is $22.93 billion

Short Term Debt

$8.32B
NVS annual short term debt is $8.32 billion

Equity & Capital

Shareholders Equity

$44.05B
NVS annual stockholders equity is $44.05 billion

Book Value

$44.05B
NVS annual book value is $44.05 billion

Retained Earnings

$46.56B
NVS annual retained earnings is $46.56 billion

Working Capital

$1.01B
NVS annual working capital is $1.01 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$17.62B
NVS annual cash flow from operations is $17.62 billion

Cash From Operations 1-year Change

+21.86%
NVS annual cash flow from operations is up +21.86% year-on-year

Cash From Investing

-$7.51B
NVS annual cash flow from investing activities is -$7.51 billion

Cash From Investing 1-year Change

-234.26%
NVS annual cash flow from investing activities is down -234.26% year-on-year

Cash From Financing

-$11.74B
NVS annual cash flow from financing activities is -$11.74 billion

Cash From Financing 1-year Change

+17.76%
NVS annual cash flow from financing activities is up +17.76% year-on-year

CAPEX

CAPEX

$3.81B
NVS annual capital expenditures is $3.81 billion

CAPEX 1-year Change

+38.54%
NVS annual capital expenditures is up +38.54% year-on-year

Free Cash Flow

Free Cash Flow

$13.80B
NVS annual free cash flow is $13.80 billion

Free Cash Flow 1-year Change

+17.94%
NVS annual free cash flow is up +17.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

75.20%
NVS annual gross profit margin is 75.20%

Operating Margin

28.12%
NVS annual operating profit margin is 28.12%

Net Margin

23.09%
NVS annual net profit margin is 23.09%

ROA & ROE

ROA

11.81%
NVS annual return on assets is 11.81%

ROE

26.28%
NVS annual return on equity is 26.28%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

19.04
NVS price to earnings ratio is 19.04

PE Ratio Sector Rank

34.95%
NVS price to earnings ratio is higher than 34.95% of companies in Healthcare sector

PB Ratio

PB Ratio

5.02
NVS price to book ratio is 5.02

PB Ratio Sector Rank

82.88%
NVS price to book ratio is higher than 82.88% of companies in Healthcare sector

PS Ratio

PS Ratio

4.28
NVS price to sales ratio is 4.28

PS Ratio Sector Rank

61.04%
NVS price to sales ratio is higher than 61.04% of companies in Healthcare sector

Enterprise value

Enterprise Value

$240.97B
NVS enterprise value is $240.97 billion

Enterprise Value Sector Rank

99.5%
NVS enterprise value is higher than 99.5% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

11.63
NVS EV/EBITDA is 11.63

EV/EBITDA Sector Rank

83.83%
NVS EV/EBITDA is higher than 83.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

1.04
NVS annual current ratio is 1.04

Quick Ratio

0.84
NVS annual quick ratio is 0.84

Leverage

Debt To Equity

0.67
NVS annual debt to equity ratio is 0.67

Interest Coverage Ratio

14.56
NVS annual interest coverage ratio is 14.56

Risk & Stability

Piotroski F-Score

7
NVS piotroski f-score is 7

Altman Z-Score

3.91
NVS altman z-score is 3.91

Analyst ratings

Recent major analysts updates

Feb 13, 25 UBS
Neutral
Nov 19, 24 Erste Group
Hold
Oct 30, 24 BMO Capital
Market Perform
Sep 11, 24 B of A Securities
Neutral
Sep 5, 24 Goldman Sachs
Neutral
Sep 3, 24 Jefferies
Hold
Jul 2, 24 Jefferies
Buy
Apr 24, 24 BMO Capital
Market Perform
Feb 23, 24 BMO Capital
Market Perform
Jan 23, 24 Morgan Stanley
Equal-Weight

Institutional Ownership

Similar stocks

MRK logo
Merck & Co (MRK)
ABT logo
Abbott Laboratories (ABT)
AZN logo
AstraZeneca (AZN)
TMO logo
Thermo Fisher Scientific (TMO)
ISRG logo
Intuitive Surgical (ISRG)
AMGN logo
Amgen (AMGN)
BSX logo
Boston Scientific (BSX)
DHR logo
Danaher (DHR)
SNY logo
Sanofi (SNY)
  • What is the ticker symbol for Novartis AG?
  • Does Novartis AG pay dividends?
  • What sector is Novartis AG in?
  • What industry is Novartis AG in?
  • What country is Novartis AG based in?
  • When did Novartis AG go public?
  • Is Novartis AG in the S&P 500?
  • Is Novartis AG in the NASDAQ 100?
  • Is Novartis AG in the Dow Jones?
  • When was Novartis AG's last earnings report?
  • When does Novartis AG report earnings?
  • Should I buy Novartis AG stock now?

What is the ticker symbol for Novartis AG?

The ticker symbol for Novartis AG is NYSE:NVS

Does Novartis AG pay dividends?

Yes, Novartis AG pays dividends. The last payment was $3.87, with an ex-dividend date on March 12, 2025

What sector is Novartis AG in?

Novartis AG is in the Healthcare sector

What industry is Novartis AG in?

Novartis AG is in the Drug Manufacturers - General industry

What country is Novartis AG based in?

Novartis AG is headquartered in Switzerland

When did Novartis AG go public?

Novartis AG's initial public offering (IPO) was on November 7, 1996

Is Novartis AG in the S&P 500?

No, Novartis AG is not included in the S&P 500 index

Is Novartis AG in the NASDAQ 100?

No, Novartis AG is not included in the NASDAQ 100 index

Is Novartis AG in the Dow Jones?

No, Novartis AG is not included in the Dow Jones index

When was Novartis AG's last earnings report?

Novartis AG's most recent earnings report was on Jan 31, 2025

When does Novartis AG report earnings?

The next expected earnings date for Novartis AG is Apr 29, 2025

Should I buy Novartis AG stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page